Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual Prevention Pill (DPP) vs Separate Pills for PrEP and Contraception in Women
NCT04778514Completed
- Sponsor
- Population Council
- Start
- Dec 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Dual Prevention Pill in human immunodeficiency virus infection (HIV) and unintended pregnancy (2 arms), sponsored by Population Council. Primary endpoints: Preference for taking a single DPP capsule versus 2 separate tablets at 24 weeks and Acceptability of taking the DPP capsule versus two separate tablets at 6 months. Started Dec 2022; status: completed.
02
Drugs
Dual Prevention Pill
03
Conditions
human immunodeficiency virus infection (HIV)unintended pregnancy
Beyond the preview
Go deeper on NCT04778514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04778514.